ライフサイエンスコーパス: luteinizing hormone

1 ailure (low/normal testosterone and elevated luteinizing hormone).

2 e, thereby inhibiting the proestrus surge in luteinizing hormone.

3 gesterone, follicle-stimulating hormone, and luteinizing hormone.

4 iosynthesis before the preovulatory surge of luteinizing hormone.

5 d all had abnormal secretion of GnRH-induced luteinizing hormone.

6 in a significant decrease in serum levels of luteinizing hormone.

7 ted by the downstream pulsatile secretion of luteinizing hormone.

8 and lower levels of endogenous estradiol and luteinizing hormone.

9 strous mice that robust pulsatile release of luteinizing hormone, a proxy for GnRH, emerges abruptly

10 Ratios of follicle stimulating hormone to luteinizing hormone, a sexual maturity indicator, in all

11 r GalNAc to N-linked oligosaccharides on the luteinizing hormone alpha subunit and CA6 but not to tho

12 We measured follicle-stimulating hormone and luteinizing hormone and added information on menstrual p

13 oproteins including the glycoprotein hormone luteinizing hormone and carbonic anhydrase-6 (CA6).

14 A limited number of glycoproteins including luteinizing hormone and carbonic anhydrase-VI (CA6) bear

15 yp2j5 (-/-) mice, but their plasma levels of luteinizing hormone and follicle stimulating hormone wer

16 The pituitary glycoprotein hormones, luteinizing hormone and follicle-stimulating hormone (FS

17 ce also have decreased circulating levels of luteinizing hormone and follicle-stimulating hormone but

18 Pituitary (luteinizing hormone and follicle-stimulating hormone) an

19 pulsatile release of gonadotropin hormones (luteinizing hormone and follicle-stimulating hormone) fr

20 gent induced high levels of the gonadotropin luteinizing hormone and increased the serum concentratio

21 e time course or the plasma concentration of luteinizing hormone and its physiological effects on the

22 -releasing hormone (GnRH) induces a surge of luteinizing hormone and ovulation in a variety of specie

23 axis and, thus, normalizes hormone levels of luteinizing hormone and testosterone.

24 restores gonadotrophin secretion, as well as luteinizing hormone and thyroid-stimulating hormone puls

25 sisting of an alpha subunit, also present in luteinizing hormone, and a unique beta subunit, which is

26 ormones: human chorionic gonadotropin, human luteinizing hormone, and follicle stimulating hormone by

27 Estradiol, progesterone, luteinizing hormone, and follicle-stimulating hormone we

28 erum levels of CRP, estradiol, progesterone, luteinizing hormone, and follicle-stimulating hormone we

29 droepiandrosterone (DHEAS), androstenedione, luteinizing hormone, and follicle-stimulating hormone.

30 d levels of follicle-stimulating hormone and luteinizing hormone, and increased variability of estrad

31 owth factor 1, follicle-stimulating hormone, luteinizing hormone, and testosterone levels).

32 for zonulin and antibodies against GnRH and luteinizing hormone, and their receptors.

33 l follicles, independently of an increase in luteinizing hormone, and this phenotype can be reversed

34 increased levels of follicle stimulating and luteinizing hormones, and 8.52-fold increased risk of Le

35 nadotropins follicle-stimulating hormone and luteinizing hormone are heterodimeric glycoproteins expr

36 estradiol, follicle-stimulating hormone, and luteinizing hormone around the woman's own mean levels w

37 e required for gonadotrope specification and luteinizing hormone beta (LH beta) gene expression.

38 hether MIP-2A can transcriptionally regulate luteinizing hormone beta (LHbeta), a pituitary-specific

39 riptional activation of both the FSHbeta and luteinizing hormone beta subunit (LHbeta) gene promoters

40 me on DNA and the binding of a TF, using the luteinizing hormone beta subunit gene (Lhb) promoter and

41 arche by regulating the transcription of the luteinizing hormone beta subunit.

42 utant mouse, whereas proopiomelanocortin and luteinizing hormone beta-subunit expression were normal

43 Tight regulation of luteinizing hormone-beta subunit (LHbeta) expression is

44 ine 3 (Org 41841), a partial agonist for the luteinizing hormone/choriogonadotropin receptor (LHCGR)

45 Signaling by the luteinizing hormone/choriogonadotropin receptor (LHR) is

46 We tested here, using hypogonadal luteinizing hormone/choriongonadotropin receptor (LHCGR)

47 The luteinizing hormone chorionic gonadotropin receptor (LHC

48 identified previously as an agonist for the luteinizing hormone/chorionic gonadotropin receptor (LHC

49 mical analysis colocalized expression of the luteinizing hormone/chorionic gonadotropin receptor, PRO

50 , and lower follicle-stimulating hormone and luteinizing hormone (each P < .01).

51 energy, vitamin E intake, physical activity, luteinizing hormone, follicle-stimulating hormone, and p

52 nophore-induced acrosome reaction as well as luteinizing hormone, follicle-stimulating hormone, and t

53 Estradiol, progesterone, luteinizing hormone, follicle-stimulating hormone, sex h

54 ycle arrested at prophase of meiosis I until luteinizing hormone from the pituitary acts on the folli

55 onding with an increase in expression of the luteinizing hormone gene, Lhb We demonstrate that poorly

56 one less than 250 ng/dL (or 8.67 nmol/L) and luteinizing hormone greater than 9.85 IU/L, and LCD by t

57 by testosterone as 250 ng/dL or greater and luteinizing hormone greater than 9.85 IU/L.

58 tein-coupled receptors (GPCRs), activated by luteinizing hormone (hLH) and essentially involved in th

59 Human luteinizing hormone (hLH) and human chorionic gonadotrop

60 Activation of the luteinizing hormone/human chorionic gonadotropin (LH/hCG

61 third transmembrane alpha-helix (TM3) of the luteinizing hormone/human chorionic gonadotropin recepto

62 Oral administration of 10b suppressed luteinizing hormone in castrated macaques.

63 es the interictal and postictal secretion of luteinizing hormone in mesial temporal lobe epilepsy.

64 ony between follicle-stimulating hormone and luteinizing hormone in the luteal phase.

65 hCGbeta evolved from the beta subunit of luteinizing hormone in two phases.

66 one administration results in suppression of luteinizing hormone in wild-type male mice, but paradoxi

67 ed puberty associated with low or apulsatile luteinizing hormone) in both humans and in the mouse mod

68 arcuate nucleus, and a reduced compensatory luteinizing hormone increase compared with control anima

69 Maximal secretion of the gonadotropin Luteinizing Hormone is supported by GLUT1 expression and

70 er (13.4+/-3.2 nmol per liter, P<0.001), the luteinizing hormone level increased from 2.7+/-2.0 to 8.

71 one, follicle-stimulating hormone level, and luteinizing hormone level were measured and testicular h

72 had higher follicle-stimulating hormone and luteinizing hormone levels and lower estradiol levels at

73 with BAY 1214784 effectively lowered plasma luteinizing hormone levels by up to 49%, at the same tim

74 , E1, E1S, follicle-stimulating hormone, and luteinizing hormone levels in all patients and the propo

75 ale mice, but paradoxically stimulates serum luteinizing hormone levels in GPRC6A(-/-) null mice.

76 estrous cycles and elevated testosterone and luteinizing hormone levels, suggesting altered hypothala

77 strongly associates with PCOS diagnosis and luteinizing hormone levels.

78 varies lacking corpora lutea and increase in luteinizing hormone levels.

79 he number of days from the midcycle surge in luteinizing hormone (LH) (P=.008).

80 s thought to be indirectly controlled by the luteinizing hormone (LH) acting through the LH/choriogon

81 Luteinizing hormone (LH) activates protein kinase A (PKA

82 Meiosis in mammalian oocytes is paused until luteinizing hormone (LH) activates receptors in the mura

83 Luteinizing hormone (LH) acts on ovarian follicles to re

84 The signaling pathway by which luteinizing hormone (LH) acts on the somatic cells of ve

85 with consequent diminished levels of plasma luteinizing hormone (LH) and correspondingly attenuated

86 esis and secretion of gonadotropic hormones, luteinizing hormone (LH) and follicle stimulating hormon

87 osynthesis and release of the gonadotropins, luteinizing hormone (LH) and follicle stimulating hormon

88 Luteinizing hormone (LH) and follicle-stimulating hormon

89 ith gonadotropic endocrine cells [expressing luteinizing hormone (LH) and follicle-stimulating hormon

90 close to follicle-stimulating hormone (FSH), luteinizing hormone (LH) and growth hormone (GH) cells.

91 ve" group (21%-23%), characterized by higher luteinizing hormone (LH) and sex hormone binding globuli

92 n, serum follicle stimulating hormone (FSH), luteinizing hormone (LH) and testosterone levels or test

93 In GnRH-CREB KO mice, basal levels of luteinizing hormone (LH) and the postovariectomy increme

94 of gonadotropin releasing hormone (GnRH) and luteinizing hormone (LH) are pivotal events in female re

95 FSH and luteinizing hormone (LH) are secreted constitutively or

96 oma cells were treated with the gonadotropin luteinizing hormone (LH) at concentrations equivalent to

97 The half-life for luteinizing hormone (LH) clearance increases in Mrc1(-/-

98 validate AutoDecon for application to serum luteinizing hormone (LH) concentration time series using

99 A surge of luteinizing hormone (LH) from the pituitary gland trigge

100 (GNRH)-stimulated synthesis and secretion of luteinizing hormone (LH) from the pituitary gonadotroph.

101 ating follicle-stimulating hormone (FSH) and luteinizing hormone (LH) gene expression in the pituitar

102 inhibited the kisspeptin-induced release of luteinizing hormone (LH) in rats and mice and blocked th

103 bone age versus the baseline measurement of luteinizing hormone (LH) in serum, used as the reference

104 or tissue remodeling process is triggered by luteinizing hormone (LH) in the ovarian follicle.

105 and then augments (positive feedback) serum luteinizing hormone (LH) increased Kiss1 mRNA density an

106 Luteinizing hormone (LH) induces maturational processes

107 The pulsatile release of luteinizing hormone (LH) is critical for mammalian ferti

108 Synthesis of luteinizing hormone (LH) is tightly controlled by a comp

109 c mouse strain that has chronically elevated luteinizing hormone (LH) levels (LH-CTP).

110 along with minimal repression of circulating luteinizing hormone (LH) levels and no change in the lip

111 The mean luteinizing hormone (LH) levels in ovariectomized rats w

112 n, follicular stimulating hormone (FSH), and luteinizing hormone (LH) levels were measured.

113 etion of GnRH is also reduced as basal serum luteinizing hormone (LH) levels were significantly lower

114 he fabrication of a nanosensor for detecting luteinizing hormone (LH) of sheep using a gold nanoparti

115 To determine whether the action of luteinizing hormone (LH) on the mouse ovarian follicle c

116 Luteinizing hormone (LH) pulsatility, body weight, ovari

117 Adult obesity is associated with blunted luteinizing hormone (LH) pulse amplitude that is partial

118 fertility, is associated with an increase in luteinizing hormone (LH) pulse frequency, implicating ab

119 from adults with previous reports of in vivo luteinizing hormone (LH) pulse frequency.

120 r cells in that they were 3betaHSD-negative, luteinizing hormone (LH) receptor (LHR)-negative, and pl

121 Recent studies suggest that luteinizing hormone (LH) receptor activation leads to tr

122 licular development, including expression of luteinizing hormone (LH) receptor by the granulosa cells

123 , an intracellular messenger formed when the luteinizing hormone (LH) receptor is activated.

124 l mechanisms play a major role in regulating luteinizing hormone (LH) receptor mRNA expression in the

125 eral motions of individual FLAG-tagged human luteinizing hormone (LH) receptors expressed on CHO cell

126 ave examined their ability to stimulate GnRH/luteinizing hormone (LH) release after peripheral or cen

127 atography was identified as OIF by eliciting luteinizing hormone (LH) release and ovulation in llamas

128 induces negative feedback on pulsatile GnRH/luteinizing hormone (LH) release and positive feedback g

129 r the female-typical cyclic surge pattern of luteinizing hormone (LH) release.

130 provides the drive necessary for tonic GnRH/luteinizing hormone (LH) release.

131 acy and duration of action) of inhibition of luteinizing hormone (LH) release.

132 easing hormone (GnRH) neurons and subsequent luteinizing hormone (LH) release.

133 es.RESULTSIn healthy women, the amplitude of luteinizing hormone (LH) rise was similar to that after

134 there is no information on the regulation of luteinizing hormone (LH) secretion by NKB or its recepto

135 positive and negative feedback control over luteinizing hormone (LH) secretion during the ovulatory

136 Locomotor activity and luteinizing hormone (LH) secretion in golden hamsters sh

137 istration of senktide (NK3R agonist) induced luteinizing hormone (LH) secretion in prepubertal and pe

138 on of these neurons would generate pulsatile luteinizing hormone (LH) secretion in vivo.

139 s characterized by the pattern of endogenous luteinizing hormone (LH) secretion on the basis of frequ

140 Changes in luteinizing hormone (LH) secretion that are observed in

141 (GnRH) neurons, which in turn supports basal luteinizing hormone (LH) secretion.

142 se mice, suggesting a mechanism for low GnRH/luteinizing hormone (LH) secretion.

143 g and follicle-stimulating hormone (FSH) and luteinizing hormone (LH) secretion.

144 s of activation required to evoke a pulse of luteinizing hormone (LH) secretion.

145 Luteinizing hormone (LH) stimulates steroidogenesis larg

146 Although mammalian oocytes ovulated after luteinizing hormone (LH) stimulation can be fertilized a

147 riggers germinal vesicle breakdown after the luteinizing hormone (LH) surge and reentry into the meio

148 have demonstrated that IL-1beta inhibits the luteinizing hormone (LH) surge during the afternoon of p

149 e in the generation of the preovulatory GnRH/luteinizing hormone (LH) surge in the female rodent.

150 linked to the induction of the preovulatory luteinizing hormone (LH) surge in the rat.

151 ntained in prophase meiotic arrest until the luteinizing hormone (LH) surge induces reentry into the

152 ut not males, to display an estrogen-induced luteinizing hormone (LH) surge is consistent with the hi

153 sures repeatedly to predict the preovulatory luteinizing hormone (LH) surge is not practical.

154 provides for the timing of the preovulatory luteinizing hormone (LH) surge necessary for ovulation i

155 irregular estrous cycles, lack a coordinated luteinizing hormone (LH) surge on the day of proestrus,

156 to escalating levels of estrogen, express a luteinizing hormone (LH) surge that is prompted by a sur

157 GnRH) surge is a prerequisite signal for the luteinizing hormone (LH) surge that triggers ovulation.

158 The midcycle luteinizing hormone (LH) surge triggers several tightly

159 the DM, up to the stage of the preovulatory luteinizing hormone (LH) surge, is impaired.

160 induction of maturation by the preovulatory luteinizing hormone (LH) surge.

161 event underlying generation of the ovulatory luteinizing hormone (LH) surge.

162 tion is induced by the preovulatory surge of luteinizing hormone (LH) that acts on the ovary and trig

163 fully grown follicles, prior to the surge of luteinizing hormone (LH) that triggers meiotic resumptio

164 at clearance rates for glycoproteins such as luteinizing hormone (LH) that undergo regulated release

165 Luteinizing hormone (LH) via activation of protein kinas

166 Serum luteinizing hormone (LH) was likewise suppressed within

167 ), follicular stimulating hormone (FSH), and luteinizing hormone (LH) were measured.

168 n-deficient mice exhibit increased levels of luteinizing hormone (LH), a pituitary hormone that regul

169 d concentrations of estradiol, progesterone, luteinizing hormone (LH), and follicle-stimulating hormo

170 mones follicle-stimulating hormone (FSH) and luteinizing hormone (LH), and that ovarian steroids exer

171 pin's follicle-stimulating hormone (FSH) and luteinizing hormone (LH), both of which are heterodimers

172 In response to luteinizing hormone (LH), cGMP in the granulosa cells de

173 The gonadotropins, luteinizing hormone (LH), follicle-stimulating hormone (

174 Estradiol, estrone, testosterone, luteinizing hormone (LH), follicle-stimulating hormone (

175 BG), dehydroepiandrosterone sulfate (DHEAS), luteinizing hormone (LH), follicle-stimulating hormone (

176 Luteinizing hormone (LH), produced in the anterior lobe

177 pins, follicle-stimulating hormone (FSH) and luteinizing hormone (LH), under the control of pulsatile

178 ine, beta-endorphin, and enkephalin) inhibit luteinizing hormone (LH), vasopressin (VP), and oxytocin

179 In response to luteinizing hormone (LH), which binds to receptors on th

180 Dendrimer 3 showed similar luteinizing hormone (LH)-release activity to triptorelin

181 ensatory elevation in levels of gonadotropin luteinizing hormone (LH).

182 ins, follicle-stimulating hormone (FSH), and luteinizing hormone (LH).

183 t measured urinary estrone-3-glucuronide and luteinizing hormone (LH).

184 tes under the pulsatile control of pituitary luteinizing hormone (LH).

185 in calcium oscillations and the secretion of luteinizing hormone (LH).

186 tory follicles resume meiosis in response to luteinizing hormone (LH).

187 se hamster ovary cells expressing either the luteinizing hormone (LH)/chorionic gonadotropin (CG) or

188 ose demonstrating the presence of functional luteinizing hormone (LH)/hCG receptors in human breast c

189 to the pituitary and the resulting surge of luteinizing hormone (LH); however, the neural circuits t

190 ol <184 pmol/l (50 pg/ml), FSH <10 IU/l, and luteinizing hormone <10 IU/l, was significantly more pre

191 t explained by any deficits in testosterone, luteinizing hormone, or follicle-stimulating hormone con

192 e generated by breeding MMTV-Neu mice with a luteinizing hormone-overexpressing mouse model of ovaria

193 /23), mainly in follicle-stimulating hormone/luteinizing hormone-producing (38%) and null cell (57%)

194 the fasting-associated decrease in overnight luteinizing hormone pulse frequency but had no effect on

195 onic epilepsy was associated with changes in luteinizing hormone pulse frequency, amplitude, and mass

196 high free testosterone, and fewer numbers of luteinizing hormone pulses, but not polycystic-appearing

197 creases in testosterone and the testosterone/luteinizing hormone ratio were detected in men watching

198 The human luteinizing hormone receptor (hLH-R) is a member of the

199 t study investigated regulation of the human luteinizing hormone receptor (hLHR) gene by histone deac

200 The luteinizing hormone receptor (LHR) and beta2-adrenergic

201 n hormones to their cognate human receptors (luteinizing hormone receptor (LHR) and thyroid-stimulati

202 n A (TSA), induces derepression of the human luteinizing hormone receptor (LHR) gene by de-recruitmen

203 Transcription of luteinizing hormone receptor (LHR) gene is activated by

204 ously demonstrated that transcription of the luteinizing hormone receptor (LHR) gene is subject to re

205 We have demonstrated that silencing of luteinizing hormone receptor (LHR) gene transcription is

206 the past decade, however, the expression of luteinizing hormone receptor (LHR) has also been reporte

207 Our previous studies have identified a luteinizing hormone receptor (LHR) mRNA-binding protein

208 mbined systematic mutagenesis studies at the luteinizing hormone receptor and the thyroid-stimulating

209 utant can inhibit signaling to G(s) from the luteinizing hormone receptor by 97% and from the calcito

210 s in the HinRs and the interhelical loops of luteinizing hormone receptor/follicle stimulating hormon

211 erize with its closely related receptor, the luteinizing hormone receptor; this association may have

212 ollicular differentiation markers, including luteinizing-hormone receptor (LHR), inhibin-alpha, micro

213 PD-PALM of two functionally defined mutant luteinizing hormone receptors (LHRs), a ligand-binding d

214 as well as human chorionic gonadotropin and luteinizing hormone receptors on male breast tissue, may

215 Increased luteinizing hormone relative to follicle-stimulating hor

216 series induced a much prolonged increase of luteinizing hormone release compared to KP10 and increas

217 Inhibition of luteinizing hormone release over time was measured in th

218 n of prostaglandin E2, which then stimulates luteinizing hormone releasing hormone (LHRH) neurons to

219 dy single-chain variable fragment (scFv) and luteinizing hormone releasing hormone (LHRH) peptide, re

220 Cytotoxic analogue of luteinizing hormone releasing hormone (LHRH), AN-207, bi

221 Irradiation of luteinizing hormone releasing hormone (LHRH), growth hor

222 n releasing hormone-1 [GnRH-1, also known as luteinizing hormone releasing hormone (LHRH)] neurons ca

223 Bilateral orchiectomy or luteinizing hormone releasing hormone agonists are the r

224 Luteinizing hormone releasing hormone analog (LHRHa, des

225 ombesin (AN-215), somatostatin (AN-238), and luteinizing hormone-releasing hormone (AN-207) consisted

226 Treatment with antagonists of luteinizing hormone-releasing hormone (LH-RH) leads to d

227 The effects of depot formulations of the luteinizing hormone-releasing hormone (LHRH) agonist Dec

228 Treatment with a luteinizing hormone-releasing hormone (LHRH) agonist inc

229 orticotropic hormone (ACTH) and hypothalamic luteinizing hormone-releasing hormone (LHRH) agonist, [D

230 Ovarian suppression with luteinizing hormone-releasing hormone (LHRH) agonists is

231 the recent developments on BPH therapy with luteinizing hormone-releasing hormone (LHRH) antagonist

232 tance and (5) a modified synthetic analog of luteinizing hormone-releasing hormone (LHRH) as a target

233 gs (prodigiosin or paclitaxel) conjugated to Luteinizing Hormone-Releasing Hormone (LHRH) for the spe

234 These drugs were functionalized with Luteinizing Hormone-Releasing hormone (LHRH) ligands who

235 Functionalized with luteinizing hormone-releasing hormone (LHRH) peptide via

236 Importantly, SSA induced by luteinizing hormone-releasing hormone (LHRH) receptor an

237 estigate the mechanism by which Mn2+ induces luteinizing hormone-releasing hormone (LHRH) secretion f

238 s by which the neuroendocrine brain controls luteinizing hormone-releasing hormone (LHRH) secretion.

239 Luteinizing hormone-releasing hormone (LHRH) was used as

240 large doses of Cetrorelix, an antagonist of luteinizing hormone-releasing hormone (LHRH), reduces le

241 naling pathway that prompts the secretion of luteinizing hormone-releasing hormone (LHRH), the neurop

242 ne (LH) surge that is prompted by a surge in luteinizing hormone-releasing hormone (LHRH).

243 othalamic neurons secreting the neuropeptide luteinizing hormone-releasing hormone (LHRH).

244 ng afferent pathways to neurons synthesizing luteinizing hormone-releasing hormone (LHRH, also known

245 (68)Ga-PSMA-11 PET imaging in hormone-naive (luteinizing hormone-releasing hormone [LHRH] +/- bicalut

246 itive tumors also received letrozole (plus a luteinizing hormone-releasing hormone [LHRH] agonist if

247 diation plus immediate androgen suppression (luteinizing hormone-releasing hormone [LHRH] agonist), w

248 steroid ablation using leuprolide acetate, a luteinizing hormone-releasing hormone agonist (LHRHa), i

249 d) (PLGA) microspheres encapsulating a model luteinizing hormone-releasing hormone agonist (LHRHa)-ba

250 Luteinizing hormone-releasing hormone agonist (LHRHa; le

251 AST, which was defined as 6 months of both a luteinizing hormone-releasing hormone agonist and an ant

252 ts receiving combined androgen blockade with luteinizing hormone-releasing hormone agonist and bicalu

253 les, followed by total androgen suppression (luteinizing hormone-releasing hormone agonist plus bical

254 tients were randomized soon after initiating luteinizing hormone-releasing hormone agonist with antia

255 n deprivation (AD) to cixutumumab added to a luteinizing hormone-releasing hormone agonist with bical

256 S; two injections of every-3-months depot of luteinizing hormone-releasing hormone agonist) to primar

257 Patients were randomly assigned 2:1 to a luteinizing hormone-releasing hormone agonist, bicalutam

258 Injectable luteinizing hormone-releasing hormone agonists (e.g., le

259 Bilateral orchiectomy or luteinizing hormone-releasing hormone agonists are recom

260 ; and three, when chemical suppression using luteinizing hormone-releasing hormone agonists is the ch

261 of 5 ng per milliliter or higher received a luteinizing hormone-releasing hormone analogue and an an

262 Whether the administration of luteinizing hormone-releasing hormone analogues (LHRHa)

263 s monotherapy or with adjuvant castration or luteinizing hormone-releasing hormone superagonists to b

264 k suggests that cytotoxic peptide analogs of luteinizing hormone-releasing hormone, somatostatin, and

265 ne and metabolic variables were measured and luteinizing hormone sampled over 8 hours on days 2 to 5

266 hormone-secreting (GH-secreting) GH3 cells, luteinizing hormone-secreting (LH-secreting) LbetaT2 cel

267 for estradiol-mediated suppression of tonic luteinizing hormone secretion (an indirect measure of Gn

268 crucial role in the regulation of pituitary luteinizing hormone secretion and reproduction.

269 Pulsatile luteinizing hormone secretion and spermatogenesis were d

270 We characterized luteinizing hormone secretion in patients with mesial te

271 rs in GnIH-ir nuclei, and GnIH inhibition of luteinizing hormone secretion indicate the discovery of

272 the stress-induced suppression in pulsatile luteinizing hormone secretion observed in control mice.

273 stent with a role in regulating preovulatory luteinizing hormone secretion, rostral projections from

274 cute seizures induced timing irregularity in luteinizing hormone secretion, whereas chronic epilepsy

275 ted a robust GnRH discharge, as reflected by luteinizing hormone secretion, which was abolished by pr

276 cocorticoid-induced suppression of pulsatile luteinizing hormone secretion.

277 In vivo GnIH administration rapidly inhibits luteinizing hormone secretion.

278 lels between MSP signaling in C. elegans and luteinizing hormone signaling in mammals.

279 g, n = 24; 12.8 nmol/kg, n = 24) to induce a luteinizing hormone surge and egg maturation.

280 otein increased >10-fold after the ovulatory luteinizing hormone surge in wild-type but not PRKO mice

281 t in the ovary for extended periods before a luteinizing hormone surge induces entry into the first m

282 eleasing hormone (GnRH) release triggers the luteinizing hormone surge that induces ovulation.

283 losa cells of periovulatory follicles by the luteinizing hormone surge through a progesterone recepto

284 han during the luteal phase (6-10 days after luteinizing hormone surge).

285 ein alters the amplitude of the preovulatory luteinizing hormone surge, likely by perturbing GnRH rel

286 n several hours after the ovulation-inducing luteinizing hormone surge, whereas they undergo differen

287 kisspeptin is involved in generation of the luteinizing hormone surge, which is required for ovulati

288 d by the puberty-triggering and preovulatory luteinizing hormone surge-mediating peptide, kisspeptin.

289 expected time of the proestrous preovulatory luteinizing hormone surge.

290 d for regulation of a full preovulatory-like luteinizing hormone surge.

291 rsting activity associated with the GnRH/LH (luteinizing hormone) surge.

292 n brain slices from a model exhibiting daily luteinizing hormone surges.

293 ecreased circulating testosterone, increased luteinizing hormone/testosterone ratio, and decreased ex

294 ens, disrupted reproductive cycles, and high luteinizing hormone, the latter reflecting increased gon

295 Luteinizing hormone then acts on receptors in outer gran

296 nts with abnormal levels of testosterone and luteinizing hormone was less pronounced-57% and 21%, res

297 estradiol, total and free testosterone, and luteinizing hormone were higher by 5.26% (95% CI: 1.27%,

298 ic antigen, thyroid stimulating hormone, and luteinizing hormone) were printed in an array format ont

299 tes pituitary synthesis of a large amount of luteinizing hormone, which is required for ovulation.

300 We used transgenic mice that overexpress luteinizing hormone with subsequent ovarian hyperstimula